Page 27 - Analysis Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Off. It was a busy earnings day dominated by corporate news. And we begin with something no one saw coming. Biotech firm biogen surprised investors when it said the experimental alzheimers treatment was ready for the Regulatory Approval press. As you may recall, seven months ago the company discontinued the study of the drug which some expected to be the next blockbuster. Analysts say the profit potential is huge because there are no current therapies to reverse affects of the disease. A disease affecting millions and projected to affect millions more in the years to come. The news sent smars ...

The hearing will come to order. This hearing is entitled congress and the frank bringing congressional mailing standards into the 21st century. I now recognize myself for five minutes to give an opening statement. Happy halloween everybody. I am dressed as americas most maligned superhero, congressman, to be able to fly across the country in six hours on alaska airlines. We were thinking about titling this hearing frankenstein, have houses ghoulish mailing standards have haunted members for decades, but i suppose we should go with the official on spooky title for the record. Like most of the i...

Where the officer was at the time of the violation . I dont have one for this reporting period. I think that should be added to the next quarter presentation thats done on e. I. S. Because thats important because these numbers although they are beautifully put into a chart they arent actually reflective or accurate of whats happening at each unit. I do want the numbers on the page 3 of the numbers that come into you and which ones you are passing through to the supervisor and which ones you are closing out. Okay. Director henderson . Thank you. I was just going to say the stuff weve been worki...

Something i know its something we didnt see as an ideal tool in our institutional context. And i think, you know, different Central Banks around the world did Different Things and we can observe how those things work, but i dont think we regard that as a firstorder tool or something we would be likely to use. There are other things that we need to look at. And i would say yield curve control, sort of shortterm yield curve control is something thats worth looking at. Not at all something that we havent looked at it, but it will be something that we look at when the time comes and the last thing...

You have under armour coming in down by 1 . Founder is actually stepping aside as head of the company. Started in his grandmothers basement. Willnder armour president become the chief executive officer on january 1. Theres a huge restructuring that planck has been under over the last few years and this is really a change in strategy. Looking for distribution and longterm growth strategy. Kevin plank stepping aside after 23 years at the helm. Procter gamble beating and raising. Ups also coming in a little bit stronger here. Its earnings view as well. Crushes it on earnings and revenue. Solid nu...